Cargando…
What is the role and authority of gatekeepers in cluster randomized trials in health research?
This article is part of a series of papers examining ethical issues in cluster randomized trials (CRTs) in health research. In the introductory paper in this series, we set out six areas of inquiry that must be addressed if the CRT is to be set on a firm ethical foundation. This paper addresses the...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443001/ https://www.ncbi.nlm.nih.gov/pubmed/22834691 http://dx.doi.org/10.1186/1745-6215-13-116 |
_version_ | 1782243498158718976 |
---|---|
author | Gallo, Antonio Weijer, Charles White, Angela Grimshaw, Jeremy M Boruch, Robert Brehaut, Jamie C Donner, Allan Eccles, Martin P McRae, Andrew D Saginur, Raphael Zwarenstein, Merrick Taljaard, Monica |
author_facet | Gallo, Antonio Weijer, Charles White, Angela Grimshaw, Jeremy M Boruch, Robert Brehaut, Jamie C Donner, Allan Eccles, Martin P McRae, Andrew D Saginur, Raphael Zwarenstein, Merrick Taljaard, Monica |
author_sort | Gallo, Antonio |
collection | PubMed |
description | This article is part of a series of papers examining ethical issues in cluster randomized trials (CRTs) in health research. In the introductory paper in this series, we set out six areas of inquiry that must be addressed if the CRT is to be set on a firm ethical foundation. This paper addresses the sixth of the questions posed, namely, what is the role and authority of gatekeepers in CRTs in health research? ‘Gatekeepers’ are individuals or bodies that represent the interests of cluster members, clusters, or organizations. The need for gatekeepers arose in response to the difficulties in obtaining informed consent because of cluster randomization, cluster-level interventions, and cluster size. In this paper, we call for a more restrictive understanding of the role and authority of gatekeepers. Previous papers in this series have provided solutions to the challenges posed by informed consent in CRTs without the need to invoke gatekeepers. We considered that consent to randomization is not required when cluster members are approached for consent at the earliest opportunity and before any study interventions or data-collection procedures have started. Further, when cluster-level interventions or cluster size means that obtaining informed consent is not possible, a waiver of consent may be appropriate. In this paper, we suggest that the role of gatekeepers in protecting individual interests in CRTs should be limited. Generally, gatekeepers do not have the authority to provide proxy consent for cluster members. When a municipality or other community has a legitimate political authority that is empowered to make such decisions, cluster permission may be appropriate; however, gatekeepers may usefully protect cluster interests in other ways. Cluster consultation may ensure that the CRT addresses local health needs, and is conducted in accord with local values and customs. Gatekeepers may also play an important role in protecting the interests of organizations, such as hospitals, nursing homes, general practices, and schools. In these settings, permission to access the organization relies on resource implications and adherence to institutional policies. |
format | Online Article Text |
id | pubmed-3443001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34430012012-09-15 What is the role and authority of gatekeepers in cluster randomized trials in health research? Gallo, Antonio Weijer, Charles White, Angela Grimshaw, Jeremy M Boruch, Robert Brehaut, Jamie C Donner, Allan Eccles, Martin P McRae, Andrew D Saginur, Raphael Zwarenstein, Merrick Taljaard, Monica Trials Research This article is part of a series of papers examining ethical issues in cluster randomized trials (CRTs) in health research. In the introductory paper in this series, we set out six areas of inquiry that must be addressed if the CRT is to be set on a firm ethical foundation. This paper addresses the sixth of the questions posed, namely, what is the role and authority of gatekeepers in CRTs in health research? ‘Gatekeepers’ are individuals or bodies that represent the interests of cluster members, clusters, or organizations. The need for gatekeepers arose in response to the difficulties in obtaining informed consent because of cluster randomization, cluster-level interventions, and cluster size. In this paper, we call for a more restrictive understanding of the role and authority of gatekeepers. Previous papers in this series have provided solutions to the challenges posed by informed consent in CRTs without the need to invoke gatekeepers. We considered that consent to randomization is not required when cluster members are approached for consent at the earliest opportunity and before any study interventions or data-collection procedures have started. Further, when cluster-level interventions or cluster size means that obtaining informed consent is not possible, a waiver of consent may be appropriate. In this paper, we suggest that the role of gatekeepers in protecting individual interests in CRTs should be limited. Generally, gatekeepers do not have the authority to provide proxy consent for cluster members. When a municipality or other community has a legitimate political authority that is empowered to make such decisions, cluster permission may be appropriate; however, gatekeepers may usefully protect cluster interests in other ways. Cluster consultation may ensure that the CRT addresses local health needs, and is conducted in accord with local values and customs. Gatekeepers may also play an important role in protecting the interests of organizations, such as hospitals, nursing homes, general practices, and schools. In these settings, permission to access the organization relies on resource implications and adherence to institutional policies. BioMed Central 2012-07-26 /pmc/articles/PMC3443001/ /pubmed/22834691 http://dx.doi.org/10.1186/1745-6215-13-116 Text en Copyright ©2012 Gallo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Gallo, Antonio Weijer, Charles White, Angela Grimshaw, Jeremy M Boruch, Robert Brehaut, Jamie C Donner, Allan Eccles, Martin P McRae, Andrew D Saginur, Raphael Zwarenstein, Merrick Taljaard, Monica What is the role and authority of gatekeepers in cluster randomized trials in health research? |
title | What is the role and authority of gatekeepers in cluster randomized trials in health research? |
title_full | What is the role and authority of gatekeepers in cluster randomized trials in health research? |
title_fullStr | What is the role and authority of gatekeepers in cluster randomized trials in health research? |
title_full_unstemmed | What is the role and authority of gatekeepers in cluster randomized trials in health research? |
title_short | What is the role and authority of gatekeepers in cluster randomized trials in health research? |
title_sort | what is the role and authority of gatekeepers in cluster randomized trials in health research? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443001/ https://www.ncbi.nlm.nih.gov/pubmed/22834691 http://dx.doi.org/10.1186/1745-6215-13-116 |
work_keys_str_mv | AT galloantonio whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT weijercharles whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT whiteangela whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT grimshawjeremym whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT boruchrobert whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT brehautjamiec whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT donnerallan whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT ecclesmartinp whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT mcraeandrewd whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT saginurraphael whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT zwarensteinmerrick whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch AT taljaardmonica whatistheroleandauthorityofgatekeepersinclusterrandomizedtrialsinhealthresearch |